Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]

The publisher regrets the conflict of interest information provided by the authors was not included in the paper and instead the incorrect statement ‘None declared’ was published. The publisher would like to apologise for any inconvenience caused.

Source: European Journal of Cancer - July 10, 2019 Category: Cancer & Oncology Authors: Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Pirkko Kellokumpu-Lehtinen, Marine Gross-Goupil, Guillermo De Velasco, Thomas Powles, Guillaume Mouillet, Yann-Alexandre Vano, Gwena ëlle Gravis, Loïc Mourey, Franck Priou, Frédéric Rollan Tags: Erratum Source Type: research